Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Skin Toxicity × Doxycycline × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Lymphoma, Non-Hodgkin 2 Immunoglobulin Light-chain Amyloidosis 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Amyloidosis 2 Waldenstrom Macroglobulinemia 1 Tissue Adhesions 1 Skin Toxicity 1 Sezary Syndrome 1 Polyps 1 Pleural Effusion, Malignant 1 Pancreatic Neoplasms 1 Pain 1 Myoma 1 Mycosis Fungoides 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, T-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Head and Neck Neoplasms 1 Exanthema 1 Endometritis 1 Colorectal Neoplasms 1 Amyloidosis, Familial 1 Advanced Malignant Neoplasm 1 AA amyloidosis 1

Interventions

Tablets 1 Doxycycline 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03448731 2020-04-08

DERMIA

Fundacion CRIS de Investigación para Vencer el Cáncer

Phase 2 Completed

Skin Toxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡